Skip to main content
Erschienen in: BMC Complementary Medicine and Therapies 1/2019

Open Access 01.12.2019 | Research article

Efficacy and safety of Curcuma longa essential oil to inactivate hydatid cyst protoscoleces

verfasst von: Hossein Mahmoudvand, Mahbobeh Pakravanan, Mohammad Reza Aflatoonian, Amal Khudair Khalaf, Massumeh Niazi, Seyyed Reza Mirbadie, Amir Tavakoli Kareshk, Mehrdad Khatami

Erschienen in: BMC Complementary Medicine and Therapies | Ausgabe 1/2019

Abstract

Background

One of the most important ways to cure hydatid cysts is surgery. Today, available chemical drugs have shown severe complications during hydatid cyst surgery. Here we investigated theefficacy and safety of Curcuma longa (C. longa) essential oil (CLEO) against hydatid cysts protoscoleces.

Methods

Here, the collected protoscoleces from fertile hydatid cysts were exposed to different concentrations of the CLEO (50–200 μl/mL) for 5–30 min in vitro and ex vivo. In addition, male NIH mice (48 mice) were applied to examine the safety of CLEO.

Results

All protoscoleces were completely killed in 5th min of treatment to the doses of 200 μl /mL of CLEO. On the other hand, in the 10th min of treatment, CLEO entirely killed 100% of protoscoleces at the dose of 100 μL/mL. Other doses of CLEO, but, revealed a postponed activity. Although CLEO at the doses of 50, and 100 μL/mL exhibited no similar effect in the ex vivo analysis; but, at the dose of 200 μL/mL and an exposure time of 5 min, approximately 100% of protoscoleces were destroyed into the cyst. We found that after intra-peritoneal injection of the CLEO for 14 days, although blood and biochemical parameters were changed; but there was no significant difference in comparison with the control group (p > 0.05).

Conclusion

This research demonstrated that C. longa revealed the promising scolicidal effects against protoscoleces in vitro and in vivo, of course, after additional tests; it might be considered as an herbal scolicidal drug in order to decrease the threat of discharge of protoscoleces through hydatid cyst surgery. Nevertheless, supplementary studies will be desired to prove the current findings by examination the essential oil in a clinical setting.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ALP
Alkaline phosphatase
ALT
Alanine aminotransferase
AST
Aspartate aminotransferase
BUN
Blood urea nitrogen
CE
Cystic echinococcosis
CLEO
Curcuma longa essential oil
Cr
Creatinine
EDTA
Ethylenediaminetetraacetic acid (EDTA) anticoagulant
GC/MS
Gas chromatography/mass spectrometry
Hb
Hemoglobin
Hct
Hematocrit
Plt
Platelet
RBC
Red blood cell
WBC
White blood cell counts

Background

Cystic echinococcosis (CE), as well known as the echinococcal disease is an infection occurred by Echinococcus granulosus which is observed in the small intestine dogs [1]. CE has been documented as a significant monetary and community well-being worry in various parts of the word particularly in developing countries [2, 3]. Humans along with domestic livestock can be the intermediary hosts in whose various organs it creates hydatid cysts [2, 3]. Because cysts are gentle-developing, infections with CE cannot create any symptoms for many years. However, the burst of cyst fluid may result in allergic responses or even death [3]. Currently, clinical managements for CE are based on surgery, percutaneous methods and chemotherapy for live cysts, as well as “watch and wait” method for silent cysts [4]. Likewise, chemotherapy with benzimidazoles has been applied to take care of hydatid cysts and demonstrated effectiveness against CE. However, they represented a range of complications such as hepatotoxicity and alopecia [4, 5]. Up to now, surgery is the favored treatment for CE, however, it has threats including those of surgical involvement, anaphylactic shocks, and secondary CE because of spilling of the contents of cyst which called protoscoleces [5, 6]. To date, available chemical drugs including 20% hypertonic saline, Ag-nitrate, and cetrimide have been applied in surgical and percutaneous methods, but they have shown severe complications for example biliary tract fibrosis, necrosis of the liver, and methemoglobinemia [7, 8]. Thus, it is compulsory to discover a perfects scolicidal agent with high effectiveness and no local or systemic complications for hydatid cyst surgery.
The use of herbs and spices has a very long history in folk medication to cure of various diseases and illnesses. Nowadays, herbal medicines supply boundless chances for discovering novel agents for therapy an extensive range of diseases as a result of possessing few complications, a low cost, and high accessibility [9]. Spices have been applied for centuries to get better the flavor and aroma of foods as well as for their medicinal properties. Spices are also famous for their antimicrobial features and are the most frequently used natural antimicrobial agents in foods [10]. In modern medicine, essential oils from various spices have been found to possess different antimicrobial effects, and the majority of them are categorized as ‘Commonly Recognized as Safe’ [11].
Curcuma longa L. from the family of Zingiberaceae with the familiar name of “turmeric” is extensively cultivated in tropical parts of Asia and Africa [11]. The plant possesses various biological activities such as anti-inflammatory, hepatoprotective, antimicrobial, wound healing, anticancer, antitumor, and antiviral ones [1214]. Previous investigations exhibited the chemical composition of C. longa essential oil (CLEO) in detail [15, 16].; however, this composition is depended on a number of factors such as geographical origin, collecting period, and environment situations are able to affect the chemical composition and bioactivity of the herbs [17]. Based on what was said we decided to evaluate the composition of CLEO, its scolicidal activity on hydatid cyst protoscoleces in vitro and ex vivo, and its safety in animal.

Methods

Plant materials

The plants materials (rhizome) were prepared from a market in Kerman province, south-east of Iran. After plant identification by a botanist, a voucher sample of the plant was placed at the Herbarium of Pharmaceutics Research Center, Kerman, Iran.

Isolation of essential oil

About 200 g of plant materials that were dried and powdered were used for isolation of essential oil through hydro-distillation method by means of a Clevenger-type device. Finally, the obtained EO was dehydrated over anhydrous sodium sulfate, and deposited in the refrigerator up to examinations [18].

Gas chromatography/mass spectrometry (GC/MS) analysis of essential oil

Here, to perform the GC analysis we used a Hewlett-Packard 6890 with a HP-5MS column (30 m × 0.25 mm, film thickness 0.25 mm). To calculate the composition percentage we used electronic integration of FID peak zones with no use of answer factors alteration. Then linear retention indices for obtained components were evaluated by coinjection of the samples with a solution comprising homologous series of C8–C22 n-alkanes. In next step, GC/MS analysis was carriedout using a Thermoquest- Finnigan gas chromatograph equipped with fused silica capillary DB-5 column (30 m × 0.25 mm, film thickness 0.25 mm) coupled with a TRACE mass (Manchester, UK). To identify the EO constituents we used the evaluation their relative retention time and mass spectra in comparison with the standards Wiley 2001 library data of the GC/MS system or literature information [19].

Collection of protoscoleces and viability

Protoscoleces were obtained from the liver of sheep infected with hydatid cyst which slaughtered at Khorramabad abattoir, Iran. The preparation of protoscoleces was performed based on the methods described elsewhere [6].; whereas the number of protoscoleces was adjusted to 2 × 103 protoscoleces with more than 90% viability.

In vitro protoscolicidal activity

In vitro protoscolicidal effects of CLEO at the doses 50, 100, and 200 μL/mL for 5, 10, 20 and 30 min was examined according to the method described elsewhere. After the protoscoleces was treated to the various doses of CLEO at the desired time, in the next step, the mortality rate of the parasites was studied by eosin test. Briefly, 50 μL of 0.1% eosin stain (Sigma-Aldrich, St. Louis, MO, USA) was added to the treated protoscoleces and then smeared on a glass slide, covered with a coverslip, and tested under a light microscope. Lastly, the mortality rate of percentages was calculated by counting killed protoscoleces in 300 protoscoleces [20]. In this test, live protoscoleces are colorless and displayed specific muscular motions and flame cell action, but due to penetration of eosin in the dead protoscoleces made it red. Normal saline containing Tween 20 and Ag-nitrate were also considered as a negative and positive control, respectively.

Ex vivo protoscolicidal activity

In this study to evaluate the ex vivo protoscolicidal activity of C. longa essential oil, liver fertile hydatid cysts acquired from naturally infected sheep and goats were used. Firstly, more than 50% of the content of the cyst was aspirated to determine the viability of protoscoleces by eosin test. For each dose of C. longa essential oil (50, 100, and 200 μL/mL) three hydatid cysts were applied. C. longa essential oil was injected to cyst. Then some of the cyst fluid along with protoscoleces was aspirated at 5, 10, 20, and 30 min and in the next step, 0.1% eosin was placed to the precipitate. Finally, the mortality rate of protoscoleces was calculated by eosin test similar to in vitro assay [21].

Toxicity effects

Animals

A total of 48 male NIH mice (6–8 weeks old) were used to this study; whereas mice were kept in a colony room with a 12:12-h light/dark cycle at room temperature. It should be mentioned that handling of mice was based on the standard rules for working with laboratory animals.

Acute toxicity

In the present study, different doses of C. longa essential oil (1–4 mL/kg) were injected intraperitoneally into four groups of six mice each to assess acute toxicity. The mortality rate of mice was calculated 24 h after the administration. Moreover, using the Probit test in SPSS software we calculated the LD50 values for this EO [22].

Determination of clinical chemistry and hematological parameters

In this investigation, the sub-acute toxicity of CLEO and subsequently evaluation of the biochemical and hematological factors was performed based on the method explained by Shakibaei et al. (2013). In summary, four groups of mice (each group contain 6 mice) were intraperitoneally received normal saline, CLEO at the doses of 0.15, 0.3, and 0.6 mL/kg, respectively, for 14 consecutive days. Following the experimental period, mice in all groups were anesthetized using Ketamine (100 mg/kg) – Xylazine (10 mg/kg); then abdomen was opened, and blood samples were collected from the heart, in the next step, sodium pentobarbital (70 mg/kg, i.p.) was applied as euthanasia drug. For hematological evaluation, some collected blood put into tubes with ethylenediaminetetraacetic acid (EDTA) anticoagulant, and subsequently a number of hematological factors such as hemoglobin (Hb), hematocrit (Hct), white blood cell counts (WBC), red blood cell (RBC), and platelet (Plt) counts were calculated.
In order to assess the biochemical parameters, after separating the serum from the remaining blood by centrifugation at 2000 g for 10 min, a number of clinical chemistry factors including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), creatinine (Cr), blood urea nitrogen (BUN), and bilirubin (direct and total) were measured by means of commercial diagnostics kits (Roche, Germany) [23].

Statistical analysis

In vitro and in vivo experiments were carried out in triplicate. The results of this study were analyzed by SPSS software (SPSS Inc., Chicago, IL, USA). One Way ANOVA as well as t-test were utilized to assess the variations among tested groups. P < 0.05 was considered statistically significant.

Results

GC/MS analysis

As shown in Table 1, 24 constituents were determined which made up nearly 95.5% of CLEO. The key constituents were α-turmerone (27.1%), β- turmerone (21.8%), l-phellandrene (8.8%), and ρ-cymene (5.4%), respectively.
Table 1
GC/MS analysis of C. longa essential oil
No
Components
KIa
% Composition
1
α- Thujene
7.434
0.7
2
α- Pinene
7.66
0.5
3
β- Myrcene
9.48
0.8
4
l-Phellandrene
9.97
8.8
5
ρ -Cymene
10.47
5.4
6
1,8-Cineole
10.72
3.7
7
Limonene
10.76
0.5
8
α- Terpineolene
12.68
0.8
9
trans-Caryophyllene
22.43
1.8
10
α-Caryophyllene
23.25
0.5
11
α-Curcumene
23.84
4.4
12
α-Zingibirene
24.25
3.2
13
β-Bisabolene
24.58
0.9
14
β-Sesquiphellandrene
24.94
4.2
15
2-Phenyl-1-D1-Aziridine
25.87
1.47
16
β- Caryophyllene
26.12
0.9
17
β-Atlantone
26.25
0.9
18
1,3,5-Cycloheptatriene
26.35
1.4
19
Pyrazine
26.45
0.7
20
β- Bisabolene
26.87
0.8
21
γ-Curcumene
27.23
2.1
22
β- Tumerone
27.90
21.8
23
Ar-Tumerone
28.10
14.7
24
α-Tumerone
28.74
12.4
25
3-Fluorophenyl isocyanate
29.91
0.5
 
α-Atlantone
30.20
1.6
Total
 
95.5
aKovats index on non-polar DB-5 ms column in reference to n-alkanes

In vitro protoscolicidal activity

Table 2 shows the in vitro scolicidal effects of different doses of CLEO. The results demonstrated that C. longa essential oil displayed considerable protoscolicidal activity in all concentrations when compared with the control group (P < 0.05) (Fig. 1). The mortality rate of protoscoleces was 100% after 5 min of treatment to the concentration of 200 μL/mL of CLEO. Moreover, after 10 min of treatment, the protoscolicidal activity of CLEO was 100% at the concentration of 100 μL/mL. In the same way, CLEO destroyed 27, 53.3, 100 and 100% of the protoscoleces at the dose of 50 μL/mL after 5, 10, 20 and 30 min of application, respectively. The results showed that with increasing treatment time to CLEO, the percentage of mortality was remarkably raised (P < 0.05). The percentage of mortality also in the negative and positive controls was 4.3% after 30 min and 100% after 5 min of treatment, respectively.
Table 2
In vitro protoscolicidal effects of C. longa essential oil against protoscoleces of hydatid cyst at various concentrations following various exposure times
Concentration (μL/mL(
Exposure time (min)
Mean of mortality rate (%)
200
5
100 ± 0.0
10
20
30
100
5
76.6 ± 3.6
10
100 ± 0.0
20
30
50
5
27.0 ± 3.15
10
53.3 ± 2.88
20
100 ± 0.0
30
Normal saline + tween 20
5
0.66 ± 0.57
10
2.6 ± 1.15
20
3.0 ± 0.5
30
4.3 ± 1.15
Ag-nitrate
5
71.6 ± 2.88
10
100 ± 0.0
20
30

Ex vivo protoscolicidal activity

Figure 2 exhibited the ex vivo protoscolicidal activity of CLEO at the doses of 50, 100, and 200 μL/mL against hydatid protoscoleces. Although CLEO at the doses of 50, and 100 μL/mL showed potent effects in vitro; but did not show the similar effect in the ex vivo analysis, needing a more time to approve a notable protoscolicidal activity. Nevertheless, at the dose of 200 μL/mL and an exposure time of 5 min, approximately killed all the protoscoleces inside the cyst.

Acute toxicity

According to the results, the LD50 value of intraperitoneal inoculation of the CLEO was 1.93 mL/kg of bw and the maximum nonfatal dose was1.16 mL/kg of body weight.

Clinical chemistry and hematological parameters

The doses of 0.15, 0.3 and 0.6 mL/kg of CLEO were chosen according to the obtained LD50. The results showed that no death was observed after 14 days of intraperitoneal administration of C. longa essential oil in doses of 0.15, 0.3 and 0.6 mL/kg. As shown in Tables 3 and 4, there was no significant difference (P > 0.05) between biochemical and hematological factors after the oral administrations of CLEO at the aforementioned doses and control.
Table 3
Clinical chemistry parameters in mice sera following oral administration of C. longa essential oil for 2 weeks
Parameters
C. longa essential (mL/kg)
Control
0.15
0.3
0.6
AST (U/L)
142.3 ± 11.5
131 ± 9.3
137 ± 12.5
141 ± 13.5
ALT (U/L)
88.6 ± 3.3
97.3 ± 4.6
104.5 ± 7.6
93.4 ± 8.3
ALP (U/L)
248.3 ± 23.3
239.6 ± 19.5
251.5 ± 20.4
235.6 ± 11.5
Cr (mg/dL)
0.4 ± 0.05
0.37 ± 0.08
0.46 ± 0.1
0.35 ± 0.05
BUN (mg/dL)
43.3 ± 7.2
29.6 ± 8.3
39.3 ± 7.1
34 ± 3.4
TB (mg/dL)
0.79 ± 0.11
0.69 ± 0.15
0.81 ± 0.2
0.76 ± 0.2
DB (mg/dL)
0.38 ± 0.06
0.28 ± 0.03
0.39 ± 0.05
0.33 ± 0.01
AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, Cr creatinine, BUN Blood urea nitrogen, TB Total bilirubin, DB Direct bilirubin
Table 4
Hematology parameters in whole blood of mice following oral administration of C. longa essential oil for 2 weeks
Parameters
C. longa essential (mL/kg)
Control
0.15
0.3
0.6
RBC (×l06/μL)
3.8 ± 0.15
3.2 ± 0.25
4.2 ± 0.41
3.4 ± 0.3
HGB (g/dL)
11.6 ± 0.7
10.7 ± 1.17
12.3 ± 0.6
11.3 ± 0.45
Hct (%)
31.6 ± 3.1
35.1 ± 2.51
35.2 ± 2.6
32.6 ± 2.18
WBC (×l03/μL)
3.3 ± 0.35
2.6 ± 0.16
3.4 ± 0.25
2.9 ± 0.2
PLT (×l03/μL)
177 ± 15
212 ± 18
197 ± 12
185 ± 17
RBC red blood cell, HGB hemoglobin, Hct hematocrit, WBC white blood cell, PLT platelet

Discussion

Historically, herbal medicines have been a popular form of complementary and alternative medicine worldwide [9]. Based on the World Health Organization (WHO) reports, in excess of 70% of the world’s people trust in folk remedy for their some health care requirements.
Since protoscolicidal agents used during hydatid cyst surgery have side effects such as sclerosing cholangitis, so more attention is paid to the toxicity of these drugs, as well as the search for a suitable alternative drug [2]. This is the first known study to evaluate the efficacy of C. longa essential oil against hydatid protoscoleces and also its safety in the mice. Results demonstrated that C. longa essential oil killed 100% of protoscoleces at the doses of 200 and 100 μL/mL after 5 and 10 min of treatment, respectively.
In this study, we established the PAIR technique, with some changes, by hydatid cysts collected from sheep livers. The scolicidal agent should fill the complete cyst cavity, seeking interaction with the protoscoleces, which occasionally are placed in the cyst. Ex vivo assay displayed that although CLEO at the doses of 50, and 100 μL/mL showed potent effects in vitro; but did not show the similar effect in the ex vivo analysis, needing a more time to approve a notable protoscolicidal activity. While, C. longa essential oil at the dose of 200 μL/mL and an treatment time of 5 min, approximately killed all the protoscoleces inside the cyst. These findings discovered that the scolicidal activity of C. longa essential oil is as good as to the current scolicidal agents such as 20% hypertonic saline, and silver nitrate, etc.
The previous study confirmed that an appropriate protoscolicidal agent is characterized by its capability at lesser doses, high efficiency in a lower time, and steadiness in the cystic contents, high accessibility, minor toxicity, and capacity for fast preparation [11]. The findings suggested that C. long might be a natural resource for producing a novel protoscolicidal drug which can used in hydatid cyst surgery.
By GC/MS analysis, The key constituents were α-turmerone (27.1%), β- turmerone (21.8%), l-phellandrene (8.8%), and ρ-cymene (5.4%), respectively. Similarly, the essential oil of C. longa rhizome has been studied in detail in a number of studies [15, 16]. and the main constituents were found to be ar-turmerone and turmerol. However, the previous studies have demonstrated that the chemical composition of EO rely on species, typical weather, harvest time, and growth step, which could change the biological characteristics of plants [17].
Turmerone and ar-turmerone are, according to their chemical structure, oxygenated sesquiterpenes of the bisabolene type, responsible for turmeric’s aroma and smell [24]. Regarding the antimicrobial mechanism of some terpenoid constituents, researchers have demonstrated that these constituents exhibit their antimicrobial mechanisms through penetration into the microbe and extinction of its cell wall [25]. On the other hand, some studies have shown that these contituents, after entering the pathogens, can display their antimicrobial mechanisms by breaking down important and vital intracellular reactions and activities [26, 27].
The obtained results revealed that the LD50 value of the C. longa essential oil was 1.93 mL/kg/bw, and the maximum nonfatal dose was 1.16 mL/kg/bw. In the present study, we examined clinical and hematological parameters in the treatment of mice receiving essential oil for 14 days to assess the sub-acute toxicity of C. longa essential oil. Liver and renal enzyme activities such as ALT, AST, ALP, Bilirubin (total, direct), Cr, and BUN are the most important characteristics of liver and renal function. Here, we observed no considerable difference (P > 0.05) in the clinical chemistry and hematological factors following intraperitoneal administrations of C. longa essential at the doses of 0.15, 0.3, and 0.6 mL/kg for 2 weeks. Therefore, based on the standard classification of toxicity, C. longa essential oil did not show any considerable toxicity against NIH mice [28].

Conclusion

The findings demonstrated that C. longa revealed the promising scolicidal effects against hydatid cyst protoscoleces in vitro and ex vivo. Nevertheless, additional studies will be desired to prove these outcomes by examination the essential oil as a new scolicidal agent in a clinical setting.

Acknowledgments

We thank the staff of the Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran for their assistance to collect the blood samples.
The protocols of this investigations are in line with the approvals of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health; which were permitted by the Committee on the Ethics of Animal Experiments of the Lorestan University of Medical Science (A-10-1633-5).
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans / WHO Informal Working Group on Echinococcosis. Bull World Health Organ. 1996;74(‎3)‎:231–42. WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans / WHO Informal Working Group on Echinococcosis. Bull World Health Organ. 1996;74(‎3)‎:231–42.
2.
Zurück zum Zitat Brunetti E, Kern P, Vuitton DA. Writing panel for the WHO-IWGE expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114(1):1–16.CrossRef Brunetti E, Kern P, Vuitton DA. Writing panel for the WHO-IWGE expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114(1):1–16.CrossRef
3.
Zurück zum Zitat Galeh TM, Spotin A, Mahami-Oskouei M, Carmena D, Rahimi MT, Barac A, Ghoyounchi R, Berahmat R, Ahmadpour E. The seroprevalence rate and population genetic structure of human cystic echinococcosis in the Middle East: a systematic review and meta-analysis. Int J Surg. 2018;51:39–48.CrossRef Galeh TM, Spotin A, Mahami-Oskouei M, Carmena D, Rahimi MT, Barac A, Ghoyounchi R, Berahmat R, Ahmadpour E. The seroprevalence rate and population genetic structure of human cystic echinococcosis in the Middle East: a systematic review and meta-analysis. Int J Surg. 2018;51:39–48.CrossRef
4.
Zurück zum Zitat McManus DP, Zhang W, Li J. Echinococcosis. Lancet. 2003;362:1295–304.CrossRef McManus DP, Zhang W, Li J. Echinococcosis. Lancet. 2003;362:1295–304.CrossRef
5.
Zurück zum Zitat Junghanss T, da Silva AM, Horton J, et al. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg. 2008;79(3):301–11.CrossRef Junghanss T, da Silva AM, Horton J, et al. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg. 2008;79(3):301–11.CrossRef
6.
Zurück zum Zitat Mahmoudvand H, Kheirandish F, Dezaki ES, Shamsaddini S, Harandi MF. Chemical composition, efficacy and safety of Pistacia vera (var. Fandoghi) to inactivate protoscoleces during hydatid cyst surgery. Biomed Pharmacother. 2016;82:393–8.CrossRef Mahmoudvand H, Kheirandish F, Dezaki ES, Shamsaddini S, Harandi MF. Chemical composition, efficacy and safety of Pistacia vera (var. Fandoghi) to inactivate protoscoleces during hydatid cyst surgery. Biomed Pharmacother. 2016;82:393–8.CrossRef
7.
Zurück zum Zitat Rajabi MA. Fatal reactions and methaemoglobinaemia after silver nitrate irrigation of hydatid cyst. Surg Pract. 2009;13:2–7.CrossRef Rajabi MA. Fatal reactions and methaemoglobinaemia after silver nitrate irrigation of hydatid cyst. Surg Pract. 2009;13:2–7.CrossRef
8.
Zurück zum Zitat Sahin M, Eryilmaz R, Bulbuloglu E. The effect of scolicidal agents on liver and biliary tree (experimental study). J Investig Surg. 2004;17(6):323–6.CrossRef Sahin M, Eryilmaz R, Bulbuloglu E. The effect of scolicidal agents on liver and biliary tree (experimental study). J Investig Surg. 2004;17(6):323–6.CrossRef
9.
Zurück zum Zitat Kohansal MH, Nourian A, Rahimi MT, Daryani A, Spotin A, Ahmadpour E. Natural products applied against hydatid cyst protoscolices: a review of past to present. Acta Trop. 2017;176:385–94.CrossRef Kohansal MH, Nourian A, Rahimi MT, Daryani A, Spotin A, Ahmadpour E. Natural products applied against hydatid cyst protoscolices: a review of past to present. Acta Trop. 2017;176:385–94.CrossRef
10.
Zurück zum Zitat Rastogi S, Pandey MM, Rawat A. Spices: therapeutic potential in cardiovascular health. Curr Pharm Des. 2017;23(7):989–98.CrossRef Rastogi S, Pandey MM, Rawat A. Spices: therapeutic potential in cardiovascular health. Curr Pharm Des. 2017;23(7):989–98.CrossRef
11.
Zurück zum Zitat Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review. Evid Based Complement Alternat Med. 2016;2016:3012462.CrossRef Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review. Evid Based Complement Alternat Med. 2016;2016:3012462.CrossRef
12.
Zurück zum Zitat Araújo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2001;96(5):723–8.CrossRef Araújo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2001;96(5):723–8.CrossRef
13.
Zurück zum Zitat Prathapan A, Singh MK, Anusree SS, Soban Kumar DR, Sundaresan A, Raghu KG. Antiperoxidative, free radical scavenging and metal chelating activities of Boerhaavia diffusa L. J Food Biochem. 2011;35:1548–54.CrossRef Prathapan A, Singh MK, Anusree SS, Soban Kumar DR, Sundaresan A, Raghu KG. Antiperoxidative, free radical scavenging and metal chelating activities of Boerhaavia diffusa L. J Food Biochem. 2011;35:1548–54.CrossRef
14.
Zurück zum Zitat Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991;57(1):1–7.CrossRef Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991;57(1):1–7.CrossRef
15.
Zurück zum Zitat Usman LA, Hamid AA, George OC, et al. Chemical composition of rhizome essential oil of Curcuma longa L. growing in north Central Nigeria. World J Chem. 2009;4(2):178–81. Usman LA, Hamid AA, George OC, et al. Chemical composition of rhizome essential oil of Curcuma longa L. growing in north Central Nigeria. World J Chem. 2009;4(2):178–81.
16.
Zurück zum Zitat Parveen Z, Nawaz S, Siddique S, Shahzad K. Composition and antimicrobial activity of the essential oil from leaves of Curcuma longa L. Kasur variety. Indian J Pharm Sci. 2013;75(1):117–22.CrossRef Parveen Z, Nawaz S, Siddique S, Shahzad K. Composition and antimicrobial activity of the essential oil from leaves of Curcuma longa L. Kasur variety. Indian J Pharm Sci. 2013;75(1):117–22.CrossRef
17.
Zurück zum Zitat Saedi Dezaki E, Mahmoudvand H, Sharififar F, Fallahi S, Monzote L, Ezatkhah F. Chemical composition along with anti-leishmanial and cytotoxic activity of Zataria multiflora. Pharm Biol. 2015;8:1–7.CrossRef Saedi Dezaki E, Mahmoudvand H, Sharififar F, Fallahi S, Monzote L, Ezatkhah F. Chemical composition along with anti-leishmanial and cytotoxic activity of Zataria multiflora. Pharm Biol. 2015;8:1–7.CrossRef
18.
Zurück zum Zitat Tavakoli Kareshk A, Keyhani A, Mahmoudvand H, et al. Efficacy of the Bunium Persicum (Boiss) essential oil against acute toxoplasmosis in mice model. Iran J Parasitol. 2015;10(4):625–31.PubMedPubMedCentral Tavakoli Kareshk A, Keyhani A, Mahmoudvand H, et al. Efficacy of the Bunium Persicum (Boiss) essential oil against acute toxoplasmosis in mice model. Iran J Parasitol. 2015;10(4):625–31.PubMedPubMedCentral
19.
Zurück zum Zitat Adams RP. Identification of essential oil components by gas chromatography/mass spectroscopy. Carol Stream: Allured Publishing Corporation; 2004. Adams RP. Identification of essential oil components by gas chromatography/mass spectroscopy. Carol Stream: Allured Publishing Corporation; 2004.
20.
Zurück zum Zitat Moazeni M, Saharkhiz MJ, Hoseini AA, Alavi AM. In vitro scolicidal effect of Satureja khuzistanica (Jamzad) essential oil. Asian Pac J Trop Biomed. 2012;2(8):616–20.CrossRef Moazeni M, Saharkhiz MJ, Hoseini AA, Alavi AM. In vitro scolicidal effect of Satureja khuzistanica (Jamzad) essential oil. Asian Pac J Trop Biomed. 2012;2(8):616–20.CrossRef
21.
Zurück zum Zitat Monteiro DU, Azevedo MI, Weiblen C, De Avila Botton S, Funk NL, DE Bona DA Silva C, Zanette RA, Schwanz TG, ML DELAR. In vitro and ex vivo activity of Melaleuca alternifolia against protoscoleces of Echinococcus ortleppi. Parasitology. 2017;144(2):214–9.CrossRef Monteiro DU, Azevedo MI, Weiblen C, De Avila Botton S, Funk NL, DE Bona DA Silva C, Zanette RA, Schwanz TG, ML DELAR. In vitro and ex vivo activity of Melaleuca alternifolia against protoscoleces of Echinococcus ortleppi. Parasitology. 2017;144(2):214–9.CrossRef
22.
Zurück zum Zitat Hosseinzadeh H, Sadeghi Shakib S, Khadem Sameni A, et al. Acute and subacute toxicity of safranal, a constituent of saffron, in mice and rats. Iran J Pharm Res. 2013;12(1):93–9.PubMedPubMedCentral Hosseinzadeh H, Sadeghi Shakib S, Khadem Sameni A, et al. Acute and subacute toxicity of safranal, a constituent of saffron, in mice and rats. Iran J Pharm Res. 2013;12(1):93–9.PubMedPubMedCentral
23.
Zurück zum Zitat Shakibaie M, Shahverdi AR, Faramarzi MA, et al. Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice. Pharm Biol. 2013;51(1):58–63.CrossRef Shakibaie M, Shahverdi AR, Faramarzi MA, et al. Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice. Pharm Biol. 2013;51(1):58–63.CrossRef
24.
Zurück zum Zitat Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081–7.CrossRef Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081–7.CrossRef
25.
Zurück zum Zitat Sikkema J, De Bont DA, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Mol Biol Rev. 1995;59:201–22. Sikkema J, De Bont DA, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Mol Biol Rev. 1995;59:201–22.
26.
Zurück zum Zitat Cristani M, D’Arrigo M, Mandalari G, et al. Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. J Agric Food Chem. 2007;55(15):6300–8.CrossRef Cristani M, D’Arrigo M, Mandalari G, et al. Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. J Agric Food Chem. 2007;55(15):6300–8.CrossRef
27.
Zurück zum Zitat Ismail A, Lamia H, Mohsen H, et al. Chemical composition and antifungal activity of three anacardiaceae species grown in Tunisia. Sci Int. 2013;1:148–54.CrossRef Ismail A, Lamia H, Mohsen H, et al. Chemical composition and antifungal activity of three anacardiaceae species grown in Tunisia. Sci Int. 2013;1:148–54.CrossRef
28.
Zurück zum Zitat Loomis TA. Essential of toxicology. Philadelphia: Lea and Febige; 1968. Loomis TA. Essential of toxicology. Philadelphia: Lea and Febige; 1968.
Metadaten
Titel
Efficacy and safety of Curcuma longa essential oil to inactivate hydatid cyst protoscoleces
verfasst von
Hossein Mahmoudvand
Mahbobeh Pakravanan
Mohammad Reza Aflatoonian
Amal Khudair Khalaf
Massumeh Niazi
Seyyed Reza Mirbadie
Amir Tavakoli Kareshk
Mehrdad Khatami
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Complementary Medicine and Therapies / Ausgabe 1/2019
Elektronische ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2527-3

Weitere Artikel der Ausgabe 1/2019

BMC Complementary Medicine and Therapies 1/2019 Zur Ausgabe